• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性肿瘤高钙血症与急性胰腺炎。

Hypercalcemia of Malignancy and Acute Pancreatitis.

机构信息

From the Department of Internal Medicine, William Beaumont Hospital.

Oakland University William Beaumont School of Medicine, Royal Oak, MI.

出版信息

Pancreas. 2021 Feb 1;50(2):206-213. doi: 10.1097/MPA.0000000000001741.

DOI:10.1097/MPA.0000000000001741
PMID:33565797
Abstract

OBJECTIVES

Hypercalcemia of malignancy confers a poor prognosis. This systematic review evaluated published cases of hypercalcemia of malignancy presenting with acute pancreatitis (AP), in terms of clinical presentation and outcomes.

METHODS

A comprehensive review of PubMed and Embase until March 18, 2020, was conducted. Studies were included if they reported on patients with hypercalcemia of malignancy and AP with attempts to exclude other etiologies of hypercalcemia and AP. Two independent reviewers selected and appraised studies using the Murad tool.

RESULTS

Thirty-seven cases were identified. Mean (standard deviation) age was 44.8 (2.46) years. Mean (standard deviation) presenting corrected calcium was 14.5 (0.46) mg/dL. Parathyroid carcinoma (21.6%) and multiple myeloma (21.6%) were the most common malignancies. Cases were classified as severe (37.8%), mild (21.6%), and moderately severe (18.9%), whereas 21.6% did not report severity. Necrotizing pancreatitis developed in 21.6% of cases. Most cases were treated with intravenous hydration and bisphosphonates or calcitonin/calcitonin analogues. Mortality was 32.4% during the same presentation of AP. Among mortality cases, 10 of 12 had severe AP, and 5 of 12 had necrotizing pancreatitis. Degree of hypercalcemia did not influence mortality.

CONCLUSION

Acute pancreatitis associated with hypercalcemia of malignancy is rare. One in 3 patients with this presentation may not survive AP.

摘要

目的

恶性肿瘤相关性高钙血症预后不良。本系统评价评估了以急性胰腺炎(AP)为表现的恶性肿瘤相关性高钙血症的病例,从临床表现和结局方面进行评估。

方法

对 PubMed 和 Embase 进行全面检索,检索截至 2020 年 3 月 18 日。纳入报道恶性肿瘤相关性高钙血症合并 AP 且尝试排除其他高钙血症和 AP 病因的病例研究。两位独立的审查员使用 Murad 工具选择和评价研究。

结果

共纳入 37 例病例。平均(标准差)年龄为 44.8(2.46)岁。平均(标准差)校正血钙为 14.5(0.46)mg/dL。甲状旁腺癌(21.6%)和多发性骨髓瘤(21.6%)是最常见的恶性肿瘤。病例分为重度(37.8%)、轻度(21.6%)和中度重度(18.9%),而 21.6%未报告严重程度。21.6%的病例发生坏死性胰腺炎。大多数病例接受静脉补液和双膦酸盐或降钙素/降钙素类似物治疗。在同一 AP 发作期间,死亡率为 32.4%。在死亡病例中,10/12 例为重度 AP,5/12 例为坏死性胰腺炎。高钙血症的严重程度并不影响死亡率。

结论

恶性肿瘤相关性高钙血症合并 AP 罕见。该表现患者中约 1/3 可能无法存活。

相似文献

1
Hypercalcemia of Malignancy and Acute Pancreatitis.恶性肿瘤高钙血症与急性胰腺炎。
Pancreas. 2021 Feb 1;50(2):206-213. doi: 10.1097/MPA.0000000000001741.
2
Quality and Outcomes of Treatment of Hypercalcemia of Malignancy.恶性肿瘤高钙血症的治疗质量与疗效
Cancer Invest. 2015;33(8):331-9. doi: 10.3109/07357907.2015.1047506. Epub 2015 Jun 12.
3
Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy.双膦酸盐与双膦酸盐联合降钙素治疗中重度恶性肿瘤高钙血症的疗效比较
Ann Pharmacother. 2021 Mar;55(3):277-285. doi: 10.1177/1060028020957048. Epub 2020 Sep 4.
4
Hypercalcemia-induced pancreatitis presenting with acute ST-elevations mimicking a myocardial infarction.
Am J Emerg Med. 2016 Jun;34(6):1187.e1-2. doi: 10.1016/j.ajem.2015.11.021. Epub 2015 Nov 10.
5
Fluid resuscitation in acute pancreatitis: Normal saline or lactated Ringer's solution?急性胰腺炎中的液体复苏:生理盐水还是乳酸林格氏液?
World J Gastroenterol. 2015 Aug 21;21(31):9367-72. doi: 10.3748/wjg.v21.i31.9367.
6
Hypercalcemia of malignancy: diagnosis and therapy.恶性肿瘤高钙血症:诊断与治疗
Compr Ther. 1986 Aug;12(8):27-32.
7
Malignancy-related hypercalcemia developing on a bisphosphonate but responding to calcitonin.在使用双膦酸盐治疗过程中出现的与恶性肿瘤相关的高钙血症,但对降钙素治疗有反应。
Clin Lung Cancer. 2007 Jul;8(7):434-5. doi: 10.3816/CLC.2007.n.028.
8
[Treatment of malignancy-associated hypercalcemia].[恶性肿瘤相关性高钙血症的治疗]
Clin Calcium. 2006 Apr;16(4):665-69.
9
Acute management of cancer-related hypercalcemia.
Ann Pharmacother. 1996 May;30(5):507-13. doi: 10.1177/106002809603000514.
10
Acute pancreatitis associated with primary hyperparathyroidism.与原发性甲状旁腺功能亢进相关的急性胰腺炎。
Updates Surg. 2011 Jun;63(2):135-8. doi: 10.1007/s13304-011-0048-9. Epub 2011 Feb 1.

引用本文的文献

1
Turkish Society of Gastroenterology: Pancreas Working Group, Acute Pancreatitis Committee Consensus Report.土耳其胃肠病学会:胰腺工作组,急性胰腺炎委员会共识报告。
Turk J Gastroenterol. 2024 Nov 11;35(Suppl 1):S1-S44. doi: 10.5152/tjg.2024.24392.
2
Acute pancreatitis and refractory hypercalcemia in the third trimester caused by parathyroid carcinoma.甲状旁腺癌导致的孕晚期急性胰腺炎和难治性高钙血症。
BMC Pregnancy Childbirth. 2024 Jul 17;24(1):483. doi: 10.1186/s12884-024-06636-3.
3
Turning Points in Cross-Disciplinary Perspective of Primary Hyperparathyroidism and Pancreas Involvements: Hypercalcemia-Induced Pancreatitis, Gene-Related Tumors, and Insulin Resistance.
原发性甲状旁腺功能亢进及其胰腺受累的跨学科转折点:高钙血症性胰腺炎、基因相关性肿瘤和胰岛素抵抗。
Int J Mol Sci. 2024 Jun 8;25(12):6349. doi: 10.3390/ijms25126349.
4
A De Novo Missense Variant in Combination with Two Inherited Missense Variants in and Detected in a Patient with Chronic Pancreatitis.在一名慢性胰腺炎患者中检测到一个新发错义变异,该变异与两个在[具体基因名称1]和[具体基因名称2]中的遗传性错义变异相结合。
Biomedicines. 2024 Jun 9;12(6):1278. doi: 10.3390/biomedicines12061278.
5
Acute pancreatitis related to hypercalcemia as initial manifestation of cancer: About 4 cases.以高钙血症为首发表现的癌症相关性急性胰腺炎:约4例。
Radiol Case Rep. 2023 Dec 3;19(2):753-759. doi: 10.1016/j.radcr.2023.11.017. eCollection 2024 Feb.
6
Changes in vitamin D and calcium-phosphorus metabolism in patients with severe acute pancreatitis.重症急性胰腺炎患者维生素D及钙磷代谢的变化
Turk J Surg. 2022 Dec 20;38(4):327-333. doi: 10.47717/turkjsurg.2022.5669. eCollection 2022 Dec.
7
Common calcium-sensing receptor (CASR) gene variants do not modify risk for chronic pancreatitis in a Hungarian cohort.常见钙敏感受体 (CASR) 基因变异不会改变匈牙利队列慢性胰腺炎的风险。
Pancreatology. 2021 Oct;21(7):1305-1310. doi: 10.1016/j.pan.2021.08.012. Epub 2021 Aug 26.